Three Jumping Small Cap Biotech or Tech Stocks: ANSU, BMSN & THNS

Last Friday, small cap biotech or tech stocks Amanasu Techno Holdings Corp (OTCMKTS: ANSU), Bio Matrix Scientific Group Inc (OTCMKTS: BMSN) and Thinspace Technology Inc (OTCBB: THNS) surged 44.74%, 42.31% and 14%, respectively, with only one of these small caps appearing to be the subject of some sort of small paid promotions or investor relations campaign. Given the lack of a big pump from promoters or IR people, will these three small caps keep surging or will the tide go out again this week? Here is a quick reality check to help you decide on a trading or investing strategy:

Amanasu Techno Holdings Corp (OTCMKTS: ANSU) Has Been Quiet When It Comes to News

Small cap Amanasu Techno Holdings Corp intends to raise capital in order to manufacture and market two technologies which the Company believes have great market potential. The first technology is a fast microbe detection system for processed and unprocessed foods, called Biomonitec Glaze by NMG Inc, a Japanese corporation while the second technology is an automated personal waste collection and cleaning machine, Haruka, developed by Nanomax Corporation in Japan. On Friday, Amanasu Techno Holdings Corp surged 44.74% to $0.157 for a market cap of $7.36 million plus ANSU is up 2,150% since last June and up 1,212.5% in intermittemt trading since March 2012 according to Google Finance.

What's the Catch With Amanasu Techno Holdings Corp? According to various disclosures, no transactions have occurred to mention Amanasu Techno Holdings Corp in various investment newsletters. Moreover, there is no news beyond filings on Yahoo! Finance's newswires for Amanasu Techno Holdings Corp. The last Form 10-Q noted how Amanasu Techno Holdings Corp decided to discontinue its business relations with Evader and abandon an electric scooter project, but the company still holds the related patents and plans to develop two other technologies. Otherwise, Amanasu Techno Holdings Corp will also be concentrating its efforts on capital raising efforts to enter into the NASDAQ Global Market with a target to raise $30,000,000 worth of capital. However:

As stated above, the Company can not predict whether or not it will be successful in its capital raising efforts and, thus, be able to satisfy its cash requirements for the next 12 months. If the Company is unsuccessful in raising at least $165,000, it may not be able to complete its plan of expanding operations as discussed above.

The company is expecting to gain the capital from issuing and selling shares of the Company.

A quick look at Amanasu Techno Holdings Corp reveals no revenues; net losses of $5k (most recent reported quarter), $18k and $3k and net income of $12k for the past four reported quarters; and $6k in cash to cover $361k in current liabilities at the end of September – meaning the company is a long way off from its capital raising goals.

Bio Matrix Scientific Group Inc (OTCMKTS: BMSN) Plans a Special Dividend

Small cap Bio Matrix Scientific Group is a biotechnology company focused on identifying undervalued regenerative medicine applications in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. On Friday, Bio Matrix Scientific Group surged 42.31% to $0.0074 for a market cap of $21.84 million plus BMSN is down 32.11% over the past year and down 95.9% over the past five years according to Google Finance.

What's the Catch With Bio Matrix Scientific Group Inc? According to various disclosures, no transactions have occurred to mention the Bio Matrix Scientific Group in various investment newsletters. Last Thursday, Bio-Matrix Scientific Group announced that March 18, 2014 will be the date for determining shareholder eligible to receive a special dividend consisting of a pro rata share of 20,000,000 Regen BioPharma common shares and its anticipated that shareholders of record will receive one share of Regen Biopharma, Inc. for every 147 shares of BMSN (Bio-Matrix Scientific Group will still be a majority owner of Regen BioPharma). Otherwise, it should be noted that last September, Bio Matrix Scientific Group filed a Form 8-K to give notice that "certain items included within the Company's Consolidated Statement of Cash Flows for the year ended September 30, 2012 and for the period from inception to September 30 2012 constituted noncash activities which do not affect Net Income and these items have been eliminated from the Company's Statements of Cash Flows." A Form 8-K/A was then filed on February 10th with the statements corrected. A look at Bio Matrix Scientific Group's financials as posted on Yahoo! Finance reveals no revenues; net losses of $914k (most recent reported quarter), $179k, $279k and $941k for the past four reported quarters; and had $269k in cash to cover $1,400k in current liabilities at the end of last December. So maybe investors should wait for more news about the company's Phase I/ II clinical trials.

Thinspace Technology Inc (OTCBB: THNS) Recently Completed a Merger With a Cloud Computing Company

Small cap Thinspace Technology is a global provider of reliable, scalable and affordable application delivery, virtualization, and cloud client technology to public and private sector companies and organizations of all sizes. On Friday, Thinspace Technology rose 14% to $0.570 for a market cap of $49.91 million plus THNS is down 63% since the start of the year and down 82.4% over the past year according to Google Finance.

What's the Catch With Thinspace Technology? According to various disclosures, a transaction or transactions of $10k has or will occur to mention Thinspace Technology in various investment newsletters. Last week was a busy week for Thinspace Technology's press release writers as the company issued four press releases. Last Friday, Thinspace Technology announced that it has brought on board a prominent technology and virtualization expert, Claudio Rodrigues, as its Chief Technical Architect while on Thursday, the company said it was "excited" to announce that it has signed a 5-year cooperation agreement with Hochschule Darmstadt University of Applied Sciences in Germany to establish and operate the THNS's worldwide testing and certification center for its current and future Panovirtualization products catered to enterprise customers. On Wednesday, Thinspace Technology announced that Managed IT Services Provider Fluid Networks had chosen to partner with the company and deploy its Propalms OneGate and Propalms TSE for secure remote access over industry giant while on Tuesday, the company said it was "excited" to announce its competitive post-merger product portfolio offering to enterprise customers of all sizes. Otherwise, it should be noted that in late February, the Vanity Events Holdings and Propalms Ltd merged entity (the merger was announced in early January) announced its name change to Thinspace Technology. For what they are worth given the merger, the predecessor entity had no revenues; a net loss of $1,804k (most recent reported quarter), net income of $6,356k and net losses of $2,626k and $2,176k for the past four quarters; and had $27k in cash to cover $11,363k in current liabilities at the end of last September. So perhaps investors should wait for a couple of more quarters worth of financials before jumping in.